This company has been marked as potentially delisted and may not be actively trading. Amedica (AMDA) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock AMDA vs. MGRM, INFU, ICAD, STSS, MBOT, NSPR, INO, SRTS, ICCM, and CTSOShould you be buying Amedica stock or one of its competitors? The main competitors of Amedica include Monogram Orthopaedics (MGRM), InfuSystem (INFU), iCAD (ICAD), Sharps Technology (STSS), Microbot Medical (MBOT), InspireMD (NSPR), Inovio Pharmaceuticals (INO), Sensus Healthcare (SRTS), IceCure Medical (ICCM), and Cytosorbents (CTSO). Amedica vs. Monogram Orthopaedics InfuSystem iCAD Sharps Technology Microbot Medical InspireMD Inovio Pharmaceuticals Sensus Healthcare IceCure Medical Cytosorbents Monogram Orthopaedics (NASDAQ:MGRM) and Amedica (NASDAQ:AMDA) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, dividends, risk, earnings, analyst recommendations, valuation, media sentiment, institutional ownership and community ranking. Is MGRM or AMDA more profitable? Monogram Orthopaedics has a net margin of 0.00% compared to Amedica's net margin of -139.62%. Monogram Orthopaedics' return on equity of -130.90% beat Amedica's return on equity.Company Net Margins Return on Equity Return on Assets Monogram OrthopaedicsN/A -130.90% -106.38% Amedica -139.62%-148.60%-67.83% Do insiders & institutionals believe in MGRM or AMDA? 0.4% of Monogram Orthopaedics shares are owned by institutional investors. Comparatively, 3.7% of Amedica shares are owned by institutional investors. 28.1% of Monogram Orthopaedics shares are owned by insiders. Comparatively, 0.9% of Amedica shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Which has more risk & volatility, MGRM or AMDA? Monogram Orthopaedics has a beta of 0.77, meaning that its share price is 23% less volatile than the S&P 500. Comparatively, Amedica has a beta of -1.24, meaning that its share price is 224% less volatile than the S&P 500. Which has higher valuation and earnings, MGRM or AMDA? Amedica has higher revenue and earnings than Monogram Orthopaedics. Monogram Orthopaedics is trading at a lower price-to-earnings ratio than Amedica, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMonogram Orthopaedics$365.00K294.88-$13.74M-$0.46-6.63Amedica$11.23M3.07-$9.32M-$3.13-0.93 Does the media favor MGRM or AMDA? In the previous week, Monogram Orthopaedics had 1 more articles in the media than Amedica. MarketBeat recorded 1 mentions for Monogram Orthopaedics and 0 mentions for Amedica. Monogram Orthopaedics' average media sentiment score of 0.62 beat Amedica's score of 0.00 indicating that Monogram Orthopaedics is being referred to more favorably in the media. Company Overall Sentiment Monogram Orthopaedics Positive Amedica Neutral Does the MarketBeat Community believe in MGRM or AMDA? Amedica received 304 more outperform votes than Monogram Orthopaedics when rated by MarketBeat users. However, 75.00% of users gave Monogram Orthopaedics an outperform vote while only 64.90% of users gave Amedica an outperform vote. CompanyUnderperformOutperformMonogram OrthopaedicsOutperform Votes375.00% Underperform Votes125.00% AmedicaOutperform Votes30764.90% Underperform Votes16635.10% Do analysts recommend MGRM or AMDA? Monogram Orthopaedics presently has a consensus price target of $5.40, indicating a potential upside of 77.05%. Given Monogram Orthopaedics' stronger consensus rating and higher probable upside, analysts clearly believe Monogram Orthopaedics is more favorable than Amedica.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Monogram Orthopaedics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50Amedica 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryMonogram Orthopaedics beats Amedica on 13 of the 19 factors compared between the two stocks. Get Amedica News Delivered to You Automatically Sign up to receive the latest news and ratings for AMDA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AMDA vs. The Competition Export to ExcelMetricAmedicaSurgical & Medical Instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$34.42M$4.39B$5.56B$7.82BDividend YieldN/A39.94%5.11%4.22%P/E Ratio-0.9330.6722.5118.48Price / Sales3.0754.91395.68103.60Price / CashN/A51.0838.1834.62Price / Book1.616.116.774.25Net Income-$9.32M$68.15M$3.22B$248.23M Amedica Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AMDAAmedicaN/A$2.90+21.3%N/A+4,285.3%$34.42M$11.23M-0.93N/AGap UpMGRMMonogram Orthopaedics2.453 of 5 stars$3.05+5.9%$5.40+77.0%+47.7%$107.63M$364,999.00-6.4928Gap DownINFUInfuSystem1.4907 of 5 stars$4.72-4.1%$13.00+175.4%-37.2%$99.20M$134.86M78.68410ICADiCAD0.5748 of 5 stars$3.42flatN/A+139.2%$93.59M$19.61M-26.31140Gap DownSTSSSharps Technology1.1928 of 5 stars$5.61+12.2%N/AN/A$91.63MN/A-0.693Short Interest ↓News CoverageGap UpHigh Trading VolumeMBOTMicrobot Medical1.8375 of 5 stars$2.47-5.7%$9.00+264.4%+165.6%$85.82MN/A-3.0920Gap DownNSPRInspireMD2.5471 of 5 stars$2.54+3.7%$4.75+87.0%+30.9%$77.81M$7.01M-3.3950News CoveragePositive NewsGap UpINOInovio Pharmaceuticals3.3423 of 5 stars$1.94+1.6%$12.20+528.9%-83.1%$71.15M$217,756.00-0.49320SRTSSensus Healthcare2.1192 of 5 stars$4.30-3.4%$13.00+202.3%+14.4%$70.93M$41.81M10.7540Upcoming EarningsNews CoverageICCMIceCure Medical2.7138 of 5 stars$1.26-0.8%$2.50+98.4%+5.9%$69.93M$3.29M-4.3460Short Interest ↓News CoverageCTSOCytosorbents1.9305 of 5 stars$1.01-9.8%$4.67+362.0%+24.7%$63.13M$35.59M-2.81220Upcoming Earnings Related Companies and Tools Related Companies Monogram Orthopaedics Competitors InfuSystem Competitors iCAD Competitors Sharps Technology Competitors Microbot Medical Competitors InspireMD Competitors Inovio Pharmaceuticals Competitors Sensus Healthcare Competitors IceCure Medical Competitors Cytosorbents Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AMDA) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredThey rigged the gameThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amedica Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Amedica With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
